The OPTIMISE trial aimed to test 7 vs 14 days for treating MDR infections in ICU patients.
Although underpowered due to early stop, no signal of inefficacy was observed for short treatments
Pseudomonas were underrepresented in this trial 🙁
@shorten2trial.bsky.social